SIRT6 regulates osteogenic differentiation of rat bone marrow mesenchymal stem cells partially via suppressing the nuclear factor-κB signaling pathway

Stem Cells

Volumn 32, Issue 7, 2014, Pages 1943-1955

  Sun, Hualing ^a   Wu, Yanru ^a   Fu, Dongjie ^a   Liu, Yinchen ^a   Huang, Cui ^a  

^a Wuhan University   (China)

Author keywords

BMSCs; Bone regeneration; Calvarial defects; Collagen chitosan HA scaffolds; Nuclear factor B; SIRT6

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; ALKALINE PHOSPHATASE; CHITOSAN; COLLAGEN; HYDROXYAPATITE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSINE; MESSENGER RNA; OSTEOCALCIN; SCAFFOLD PROTEIN; SIRTUIN 6; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RUNX2; RUNX2 PROTEIN, RAT; SIRTUIN; SIRTUIN 6, RAT;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; BONE GROWTH; BONE MINERALIZATION; BONE REGENERATION; CELL DIFFERENTIATION; CELL GROWTH; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HISTOLOGY; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSSIFICATION; OSTEOGENIC DIFFERENTIATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; SKULL DEFECT; UPREGULATION; ANIMAL; CELL ADHESION; CELL CULTURE; ENZYMOLOGY; GENE EXPRESSION; GENETICS; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ALKALINE PHOSPHATASE; ANIMALS; BONE REGENERATION; CELL ADHESION; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NF-KAPPA B; OSTEOCALCIN; OSTEOGENESIS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SIRTUINS;

EID: 84902590029     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1671     Document Type: Article

References (62)

1. Chien KR, Karsenty G,. Longevity and lineages: Toward the integrative biology of degenerative diseases in heart, muscle, and bone. Cell 2005; 120: 533-544.
2. Jilka RL,. Osteoblast progenitor fate and age-related bone loss. J Musculoskelet Neuronal Interact 2002; 2: 581-583.
3. Kanfi Y, Naiman S, Amir G, et al. The sirtuin SIRT6 regulates lifespan in male mice. Nature 2012; 483: 218-221.
4. Mostoslavsky R, Chua KF, Lombard DB, et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 2006; 124: 315-329.
5. Michishita E, McCord RA, Berber E, et al. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 2008; 452: 492-496.
6. Xiao C, Wang RH, Lahusen TJ, et al. Progression of chronic liver inflammation and fibrosis driven by activation of c-JUN signaling in Sirt6 mutant mice. J Biol Chem 2012; 287: 41903-41913.
7. Larsen SA, Kassem M, Rattan SI,. Glucose metabolite glyoxal induces senescence in telomerase-immortalized human mesenchymal stem cells. Chem Cent J 2012; 6: 18.
8. Mao Z, Hine C, Tian X, et al. SIRT6 promotes DNA repair under stress by activating PARP1. Science 2011; 332: 1443-1446.
9. Kaidi A, Weinert BT, Choudhary C, et al. Human SIRT6 promotes DNA end resection through CtIP deacetylation. Science 2010; 329: 1348-1353.
10. Mahlknecht U, Ho AD, Voelter-Mahlknecht S,. Chromosomal organization and fluorescence in situ hybridization of the human Sirtuin 6 gene. Int J Oncol 2006; 28: 447-456.
11. Novack DV,. Role of NF-κB in the skeleton. Cell Res 2011; 21: 169-182.
12. Chang J, Wang Z, Tang E, et al. Inhibition of osteoblastic bone formation by nuclear factor-κB. Nat Med 2009; 15: 682-689.
13. Vaira S, Alhawagri M, Anwisye I, et al. RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice. J Clin Invest 2008; 118: 2088-2097.
14. Edwards JR, Perrien DS, Fleming N, et al. Silent information regulator (Sir)T1 inhibits NF-κB signaling to maintain normal skeletal remodeling. J Bone Miner Res 2013; 28: 960-969.
15. Kawahara TL, Michishita E, Adler AS, et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-κB-dependent gene expression and organismal life span. Cell 2009; 136: 62-74.
16. Yu SS, Cai Y, Ye JT, et al. Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-κB-dependent transcriptional activity. Br J Pharmacol 2013; 168: 117-128.
17. Baohua Y, Li L,. Effects of SIRT6 silencing on collagen metabolism in human dermal fibroblasts. Cell Biol Int 2012; 36: 105-108.
18. Cai B, Li J, Wang J, et al. microRNA-124 regulates cardiomyocyte differentiation of bone marrow-derived mesenchymal stem cells via targeting STAT3 signaling. Stem Cells 2012; 30: 1746-1755.
19. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408.
20. Rajan N, Habermehl J, Cote MF, et al. Preparation of ready-to-use, storable and reconstituted type I collagen from rat tail tendon for tissue engineering applications. Nat Protoc 2006; 1: 2753-2758.
21. Wang X, Tan Y, Zhang B, et al. Synthesis and evaluation of collagen-chitosan-hydroxyapatite nanocomposites for bone grafting. J Biomed Mater Res A 2009; 89: 1079-1087.
22. Ma L, Gao C, Mao Z, et al. Collagen/chitosan porous scaffolds with improved biostability for skin tissue engineering. Biomaterials 2003; 24: 4833-4841.
23. Chimutengwende-Gordon M, Khan WS,. Advances in the use of stem cells and tissue engineering applications in bone repair. Curr Stem Cell Res Ther 2012; 7: 122-126.
24. Kimelman N, Pelled G, Helm GA, et al. Review: Gene- and stem cell-based therapeutics for bone regeneration and repair. Tissue Eng 2007; 13: 1135-1150.
25. Kitada M, Kume S, Takeda-Watanabe A, et al. Sirtuins and renal diseases: Relationship with aging and diabetic nephropathy. Clin Sci (Lond) 2013; 124: 153-164.
26. Gertler AA, Cohen HY,. SIRT6, a protein with many faces. Biogerontology 2013; 14: 629-639.
27. Tennen RI, Bua DJ, Wright WE, et al. SIRT6 is required for maintenance of telomere position effect in human cells. Nat Commun 2011; 2: 433.
28. Pan PW, Feldman JL, Devries MK, et al. Structure and biochemical functions of SIRT6. J Biol Chem 2011; 286: 14575-14587.
29. Kanfi Y, Peshti V, Gil R, et al. SIRT6 protects against pathological damage caused by diet-induced obesity. Aging Cell 2010; 9: 162-173.
30. Xiao C, Kim HS, Lahusen T, et al. SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulin-stimulated glucose uptake in mice. J Biol Chem 2010; 285: 36776-36784.
31. Zhong L, D'Urso A, Toiber D, et al. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell 2010; 140: 280-293.
32. Chang CS, Chang YF, Wang MW, et al. Inverse relationship between central obesity and osteoporosis in osteoporotic drug naive elderly females: The Tianliao Old People (TOP) Study. J Clin Densitom 2013; 16: 204-211.
33. Zhao LJ, Liu YJ, Liu PY, et al. Relationship of obesity with osteoporosis. J Clin Endocrinol Metab 2007; 92: 1640-1646.
34. Piao J, Tsuji K, Ochi H, et al. Sirt6 regulates postnatal growth plate differentiation and proliferation via Ihh signaling. Sci Rep 2013; 3: 3022.
35. Michishita E, Park JY, Burneskis JM, et al. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell 2005; 16: 4623-4635.
36. Tennen RI, Berber E, Chua KF,. Functional dissection of SIRT6: Identification of domains that regulate histone deacetylase activity and chromatin localization. Mech Ageing Dev 2010; 131: 185-192.
37. Sebastian C, Zwaans BM, Silberman DM, et al. The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 2012; 151: 1185-1199.
38. Schneider RK, Puellen A, Kramann R, et al. The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodelling in three-dimensional collagen scaffolds. Biomaterials 2010; 31: 467-480.
39. Huang DM, Hsiao JK, Chen YC, et al. The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles. Biomaterials 2009; 30: 3645-3651.
40. Shakibaei M, Shayan P, Busch F, et al. Resveratrol mediated modulation of Sirt-1/Runx2 promotes osteogenic differentiation of mesenchymal stem cells: Potential role of Runx2 deacetylation. PLoS One 2012; 7: e35712.
41. Simic P, Zainabadi K, Bell E, et al. SIRT1 regulates differentiation of mesenchymal stem cells by deacetylating beta-catenin. EMBO Mol Med 2013; 5: 430-440.
42. Tseng PC, Hou SM, Chen RJ, et al. Resveratrol promotes osteogenesis of human mesenchymal stem cells by upregulating RUNX2 gene expression via the SIRT1/FOXO3A axis. J Bone Miner Res 2011; 26: 2552-2563.
43. Bosch-Presegue L, Vaquero A,. The dual role of sirtuins in cancer. Genes Cancer 2011; 2: 648-662.
44. Kim HS, Xiao C, Wang RH, et al. Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. Cell Metab 2010; 12: 224-236.
45. Bosch-Marce M, Okuyama H, Wesley JB, et al. Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ Res 2007; 101: 1310-1318.
46. Salminen A, Kaarniranta K,. NF-κB signaling in the aging process. J Clin Immunol 2009; 29: 397-405.
47. Grimley R, Polyakova O, Vamathevan J, et al. Over expression of wild type or a catalytically dead mutant of Sirtuin 6 does not influence NFκB responses. PLoS One 2012; 7: e39847.
48. Sen R, Baltimore D,. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986; 46: 705-716.
49. Caamano J, Hunter CA,. NF-κB family of transcription factors: Central regulators of innate and adaptive immune functions. Clin Microbiol Rev 2002; 15: 414-429.
50. Helenius M, Kyrylenko S, Vehvilainen P, et al. Characterization of aging-associated up-regulation of constitutive nuclear factor-κB binding activity. Antioxid Redox Signal 2001; 3: 147-156.
51. Spencer NF, Poynter ME, Im SY, et al. Constitutive activation of NF-κB in an animal model of aging. Int Immunol 1997; 9: 1581-1588.
52. Xu X, Woo CH, Steere RR, et al. EVI1 acts as an inducible negative-feedback regulator of NF-κB by inhibiting p65 acetylation. J Immunol 2012; 188: 6371-6380.
53. Beauharnois JM, Bolivar BE, Welch JT,. Sirtuin 6: A review of biological effects and potential therapeutic properties. Mol Biosyst 2013; 9: 1789-1806.
54. Chen LF, Mu Y, Greene WC,. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-κB. EMBO J 2002; 21: 6539-6548.
55. Lee HS, Ka SO, Lee SM, et al. Overexpression of sirtuin 6 suppresses inflammatory responses and bone destruction in mice with collagen-induced arthritis. Arthritis Rheum 2013; 65: 1776-1785.
56. Huang Y, Zhou G, Zheng L, et al. Micro-/nano- sized hydroxyapatite directs differentiation of rat bone marrow derived mesenchymal stem cells towards an osteoblast lineage. Nanoscale 2012; 4: 2484-2490.
57. Frohbergh ME, Katsman A, Botta GP, et al. Electrospun hydroxyapatite-containing chitosan nanofibers crosslinked with genipin for bone tissue engineering. Biomaterials 2012; 33: 9167-9178.
58. Suh JK, Matthew HW,. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: A review. Biomaterials 2000; 21: 2589-2598.
59. Bhardwaj N, Kundu SC,. Chondrogenic differentiation of rat MSCs on porous scaffolds of silk fibroin/chitosan blends. Biomaterials 2012; 33: 2848-2857.
60. Burg KJ, Porter S, Kellam JF,. Biomaterial developments for bone tissue engineering. Biomaterials 2000; 21: 2347-2359.
61. Wang L, Liu Y, Kalajzic Z, et al. Heterogeneity of engrafted bone-lining cells after systemic and local transplantation. Blood 2005; 106: 3650-3657.
62. Li F, Wang X, Niyibizi C,. Bone marrow stromal cells contribute to bone formation following infusion into femoral cavities of a mouse model of osteogenesis imperfecta. Bone 2010; 47: 546-555.